Search results
Results from the WOW.Com Content Network
Sudhir M. Parikh is an American medical doctor of Indian origin, known for his expertise in the treatment of Asthma and allergies [1] and for his social activities. [ 2 ] [ 3 ] The Government of India honoured him, in 2010, with the award of Padma Shri , the fourth highest civilian award, for his contributions to the field of social service.
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a ...
In the initial evaluation of sinusitis an Otolaryngologist, also known as an ear, nose and throat (ENT) doctor, may confirm sinusitis using nasal endoscopy. [11] Diagnostic imaging is not usually needed in acute stage unless complications are suspected. [13] In chronic cases, confirmatory testing is recommended by use of computed tomography. [13]
The Allergy and Immunology Clinical Fellowship Program is open to physicians who are on track to complete an approved internal medicine or pediatric medicine residency program. [19] Fellows are eligible to sit for the Board of Allergy and Immunology certification examination after two years.
The doctor gave her an injectable medication to try to see what was happening with her heart, but she developed a headache. “They said, ‘Well, your blood pressure is high, that’s why you ...
[8] National Jewish adopted the motto: "None may enter who can pay – none can pay who enter" [10] The hospital opened with a capacity of 60 patients with the goal of treating 150 patients a year. In the beginning, a six-month limit on patient stays was imposed and only patients in the early stages of tuberculosis were to be accepted.
From January 2008 to December 2012, if you bought shares in companies when V.J. Tschinkel joined the board, and sold them when she left, you would have a 16.7 percent return on your investment, compared to a -2.8 percent return from the S&P 500.